Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mizuno, S.-i.
Right arrow Articles by Sasaki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mizuno, S.-i.
Right arrow Articles by Sasaki, H.
Related Collections
Right arrow Plenary Papers
Right arrow Gene Expression
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 March 2001, Vol. 97, No. 5, pp. 1172-1179

PLENARY PAPER

Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia

Shin-ichi Mizuno, Takahito Chijiwa, Takashi Okamura, Koichi Akashi, Yasuyuki Fukumaki, Yoshiyuki Niho, and Hiroyuki Sasaki

Aberrant hypermethylation of tumor suppressor genes plays an important role in the development of many tumors. Recently identified new DNA methyltransferase (DNMT) genes, DNMT3A and DNMT3B, code for de novo methyltransferases. To determine the roles of DNMT3A, DNMT3B, as well as DNMT1, in the development of leukemia, competitive polymerase chain reaction (PCR) assays were performed and the expression levels of DNMTs were measured in normal hematopoiesis, 33 cases of acute myelogenous leukemia (AML), and 17 cases of chronic myelogenous leukemia (CML). All genes were constitutively expressed, although at different levels, in T lymphocytes, monocytes, neutrophils, and normal bone marrow cells. Interestingly, DNMT3B was expressed at high levels in CD34+ bone marrow cells but down-regulated in differentiated cells. In AML, 5.3-, 4.4-, and 11.7-fold mean increases were seen in the levels of DNMT1, 3A, and 3B, respectively, compared with the control bone marrow cells. Although CML cells in the chronic phase did not show significant changes, cells in the acute phase showed 3.2-, 4.5-, and 3.4-fold mean increases in the levels of DNMT1, 3A, and 3B, respectively. Using methylation-specific PCR, it was observed that the p15INAK4B gene, a cell cycle regulator, was methylated in 24 of 33 (72%) cases of AML. Furthermore, AML cells with methylated p15INAK4B tended to express higher levels of DNMT1 and 3B. In conclusion, DNMTs were substantially overexpressed in leukemia cells in a leukemia type- and stage-specific manner. Up-regulated DNMTs may contribute to the pathogenesis of leukemia by inducing aberrant regional hypermethylation.

© 2001 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
R. Garzon, S. Liu, M. Fabbri, Z. Liu, C. E.A. Heaphy, E. Callegari, S. Schwind, J. Pang, J. Yu, N. Muthusamy, et al.
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1
Blood, June 18, 2009; 113(25): 6411 - 6418.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Qin, J. Jelinek, J. Si, J. Shu, and J.-P. J. Issa
Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines
Blood, January 15, 2009; 113(3): 659 - 667.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. Hoelzer, L. A. Shackelton, and C. R. Parrish
Presence and role of cytosine methylation in DNA viruses of animals
Nucleic Acids Res., May 1, 2008; 36(9): 2825 - 2837.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. B. Klisovic, W. Stock, S. Cataland, M. I. Klisovic, S. Liu, W. Blum, M. Green, O. Odenike, L. Godley, J. V. Burgt, et al.
A Phase I Biological Study of MG98, an Oligodeoxynucleotide Antisense to DNA Methyltransferase 1, in Patients with High-Risk Myelodysplasia and Acute Myeloid Leukemia
Clin. Cancer Res., April 15, 2008; 14(8): 2444 - 2449.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Liu, Z. Liu, Z. Xie, J. Pang, J. Yu, E. Lehmann, L. Huynh, T. Vukosavljevic, M. Takeki, R. B. Klisovic, et al.
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-{kappa}B-dependent DNA methyltransferase activity in acute myeloid leukemia
Blood, February 15, 2008; 111(4): 2364 - 2373.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. A. Murray, A. K.E. Swales, R. E. Smith, M. D. Molinek, S. G. Hillier, and N. Spears
Follicular growth and oocyte competence in the in vitro cultured mouse follicle: effects of gonadotrophins and steroids
Mol. Hum. Reprod., February 1, 2008; 14(2): 75 - 83.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Akimzhanov, L. Krenacs, T. Schlegel, S. Klein-Hessling, E. Bagdi, E. Stelkovics, E. Kondo, S. Chuvpilo, P. Wilke, A. Avots, et al.
Epigenetic Changes and Suppression of the Nuclear Factor of Activated T Cell 1 (NFATC1) Promoter in Human Lymphomas with Defects in Immunoreceptor Signaling
Am. J. Pathol., January 1, 2008; 172(1): 215 - 224.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
T. de Almeida Simao, G. L. De Bonis Almeida Simoes, F. S. Ribeiro, D. A. de Paula Cidade, N. A. Andreollo, L. R. Lopes, J. M. B. Macedo, R. Acatauassu, A. M. R. Teixeira, I. Felzenszwalb, et al.
Lower expression of p14ARF and p16INK4a correlates with higher DNMT3B expression in human oesophageal squamous cell carcinomas
Human and Experimental Toxicology, September 1, 2006; 25(9): 515 - 522.
[Abstract] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Lin, Y. Yamada, S. Nguyen, H. Linhart, L. Jackson-Grusby, A. Meissner, K. Meletis, G. Lo, and R. Jaenisch
Suppression of Intestinal Neoplasia by Deletion of Dnmt3b
Mol. Cell. Biol., April 15, 2006; 26(8): 2976 - 2983.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. T. McCabe, J. A. Low, S. Daignault, M. J. Imperiale, K. J. Wojno, and M. L. Day
Inhibition of DNA Methyltransferase Activity Prevents Tumorigenesis in a Mouse Model of Prostate Cancer
Cancer Res., January 1, 2006; 66(1): 385 - 392.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. A. Ortmann, A. Burchert, K. Holzle, A. Nitsche, B. Wittig, A. Neubauer, and M. Schmidt
Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region
Nucleic Acids Res., December 7, 2005; 33(21): 6895 - 6905.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
A K E Swales and N Spears
Genomic imprinting and reproduction
Reproduction, October 1, 2005; 130(4): 389 - 399.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. E. Blanco-Betancourt, A. Moncla, M. Milili, Y. L. Jiang, E. M. Viegas-Pequignot, B. Roquelaure, I. Thuret, and C. Schiff
Defective B-cell-negative selection and terminal differentiation in the ICF syndrome
Blood, April 1, 2004; 103(7): 2683 - 2690.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. Girault, S. Tozlu, R. Lidereau, and I. Bieche
Expression Analysis of DNA Methyltransferases 1, 3A, and 3B in Sporadic Breast Carcinomas
Clin. Cancer Res., October 1, 2003; 9(12): 4415 - 4422.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. Roman-Gomez, J. A. Castillejo, A. Jimenez, F. Cervantes, C. Boque, L. Hermosin, A. Leon, A. Granena, D. Colomer, A. Heiniger, et al.
Cadherin-13, a Mediator of Calcium-Dependent Cell-Cell Adhesion, Is Silenced by Methylation in Chronic Myeloid Leukemia and Correlates With Pretreatment Risk Profile and Cytogenetic Response to Interferon Alfa
J. Clin. Oncol., April 15, 2003; 21(8): 1472 - 1479.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Zhan, J. Hardin, B. Kordsmeier, K. Bumm, M. Zheng, E. Tian, R. Sanderson, Y. Yang, C. Wilson, M. Zangari, et al.
Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells
Blood, March 1, 2002; 99(5): 1745 - 1757.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. R. Hodge, W. Xiao, P. A. Clausen, G. Heidecker, M. Szyf, and W. L. Farrar
Interleukin-6 Regulation of the Human DNA Methyltransferase (HDNMT) Gene in Human Erythroleukemia Cells
J. Biol. Chem., October 19, 2001; 276(43): 39508 - 39511.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J.-Y. Fang, J. A. Mikovits, R. Bagni, C. L. Petrow-Sadowski, and F. W. Ruscetti
Infection of Lymphoid Cells by Integration-Defective Human Immunodeficiency Virus Type 1 Increases De Novo Methylation
J. Virol., October 15, 2001; 75(20): 9753 - 9761.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. A. Sweetser, C.-S. Chen, A. A. Blomberg, D. A. Flowers, P. C. Galipeau, M. T. Barrett, N. A. Heerema, J. Buckley, W. G. Woods, I. D. Bernstein, et al.
Loss of heterozygosity in childhood de novo acute myelogenous leukemia
Blood, August 15, 2001; 98(4): 1188 - 1194.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020